)
Edge28 Aug 2026
Bigger, Sharper, IMAX: A Blockbuster Business
How IMAX turned an unscalable, large-screen format into the center of blockbuster filmmaking through cameras, projection, and remastering technology.
Ambu
Ambu (AMBU) investor relations material
Ambu Q3 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 25/26 earnings summary26 Aug, 2026
Executive summary
Organic revenue grew 10.3% year-over-year in Q3 2025/26, led by 16% growth in Endoscopy Solutions and strong innovation in Respiratory and Urology, with market share gains across all endoscopy areas.
EBIT margin improved to 13.5%, supported by operating leverage and tariff refunds, despite increased commercial investments.
Endoscopy Solutions now represents 64% of total revenue, with A&PM at 36%.
Free cash flow before acquisitions rose to DKK 154m, with cash conversion at 48%.
Strategic launches included SureSight Mobile, EndoIntelligence platform, and expansion of the Recircle recycling program.
Financial highlights
Q3 revenue reached DKK 1,640m, with reported growth of 8.8% due to FX headwinds.
Gross margin improved by 0.6 percentage points year-over-year to 59.5%.
EBIT of DKK 221m, up from DKK 170m year-over-year; net profit DKK 156m.
Cash flow from operating activities was DKK 331m; cash and cash equivalents at period end DKK 705m.
OPEX ratio improved to 46.0% and ROIC at 9%.
Outlook and guidance
Organic revenue growth guidance for FY 2025/26 updated to around 10%, with Endoscopy Solutions expected to maintain over 15% growth.
EBIT margin guidance maintained at 12%-14%, expected at the high end due to tariff refunds.
Cash conversion for the full year expected above 40%.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Ambu
- Endoscopy Solutions drove growth as guidance narrowed and share buyback expanded to DKK 450m.AMBU
Q2 25/26 - Q1 saw 8.6% organic revenue growth and 10.5% EBIT margin, led by Endoscopy Solutions.AMBUQ1 25/26
- Leading single-use endoscopy with 60%+ share, targeting double-digit growth and margin expansion.AMBUSEB Nordic Seminar presentation
- Double-digit growth and innovation drive global endoscopy leadership ambitions.AMBU44th Annual J.P. Morgan Healthcare Conference
- Strategy targets 11%-13% organic revenue CAGR and >20% EBIT margin by 2029/2030.AMBUCMD 2025
- Strong growth and profitability, with robust outlook despite GI impairment.AMBUQ4 23/24
- 15% organic growth, margin expansion, and upgraded guidance highlight strong Q3 performance.AMBUQ3 23/24
- Raised guidance after strong Q1; endoscopy leads growth with new launches and operational gains.AMBU43rd Annual J.P. Morgan Healthcare Conference 2025
- Q1 2024/25 saw 19.5% organic growth, margin expansion, and upgraded guidance.AMBUQ1 24/25
Next Ambu earnings date
Q4 25/265 Nov, 2026
Ambu
Next Ambu earnings date
Q4 25/265 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage